The use of levofloxacin versus amoxycillin/clavulanic acid combined with azithromycin in treatment of community acquired pneumonia

Levofloxacin versus amoxycillin/clavulanic acid combined with azithromycin in treatment of community acquired pneumonia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202308507206446

Enrollment

Registered

2023-08-03

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory

Interventions

Levofloxacin alone

AmoxycillinClavulanic and azithromycin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosed with CAP in outpatient Gives verbal consent

Exclusion criteria

Exclusion criteria: Allergic to levofloxacin allergic to amoxycillin allergic to azithromycin

Design outcomes

Primary

Measure	Time frame
Reduced body temperature, normal respiratory rate, normalized white blood cell count	—

Secondary

Measure	Time frame
Reduced cough, absent crackles	—

Countries

Kenya

Contacts

Public ContactVincent Musungu

Jaramogi Odinga Oginga University of science and technology

vinn.musungu@gmail.com+254728556330

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026